RxDoctor Payments Data

Athos Patsalides, MD

Neuroradiology · New York, NYNPI 1447409164

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (59.4%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by Microvention, Inc. at 40.1% of the total. Reporting peaked in 2019 at $16,831 and has fallen 81.0% since, to $3,200 in 2025.

$32,388in general payments, 2019–2025

Across 211 payments — averaging $153.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Microvention, Inc.$13K
  • Penumbra, Inc.$12K
  • Balt USA, LLC$3K
  • Qapel Medical Inc$2K
  • Stryker$1K
  • Medtronic$1K
  • plus $273 from 5 others
$19,919in research payments, 2019–2025

Across 5 payments — averaging $3983.70 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Lenoss Medical Inc$12K
  • Penumbra, Inc.$8K

What the payments were for

  • Consulting fees$2,3757%
  • Speaking & faculty fees$19,25059%
  • Travel & lodging$2,5758%
  • Food & beverage$8,18725%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Microvention, Inc.38$12,976
Penumbra, Inc.58$12,211
Balt USA, LLC10$2,867
Qapel Medical Inc4$1,583
Stryker52$1,378
Medtronic(2 entities)36$1,100
Cordis US CORP.6$104
Johnson & Johnson3$57
Phenox Inc.1$47
Inspiremd Ltd2$34
Route 92 Medical, Inc.1$32

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$32,388 in reported general payments places this provider in the 85th percentile of 71 neuroradiology providers in New York.

See all neuroradiology providers in New York

Medicare billing

Part B allowed, 2024
$101,664
Medicare patients
165
Services billed
530

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neuroradiology in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →